Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| adipocyte | 9 studies | 46% ± 17% | |
| macrophage | 5 studies | 22% ± 10% | |
| endothelial cell | 4 studies | 20% ± 5% | |
| epithelial cell | 4 studies | 25% ± 2% | |
| astrocyte | 4 studies | 28% ± 7% | |
| glutamatergic neuron | 4 studies | 28% ± 7% | |
| GABAergic neuron | 3 studies | 24% ± 6% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| brain | 4 studies | 21% ± 6% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| breast | 100% | 5703.47 | 457 / 459 | 96% | 10.99 | 1076 / 1118 |
| esophagus | 100% | 2715.96 | 1439 / 1445 | 95% | 17.39 | 174 / 183 |
| thymus | 100% | 2986.66 | 653 / 653 | 93% | 6.26 | 564 / 605 |
| ovary | 100% | 3233.50 | 180 / 180 | 90% | 7.04 | 389 / 430 |
| brain | 90% | 1049.89 | 2391 / 2642 | 99% | 9.83 | 699 / 705 |
| lung | 100% | 3449.46 | 578 / 578 | 89% | 11.19 | 1024 / 1155 |
| adrenal gland | 100% | 9408.74 | 258 / 258 | 83% | 6.19 | 190 / 230 |
| prostate | 100% | 2552.36 | 244 / 245 | 80% | 3.65 | 404 / 502 |
| bladder | 100% | 2148.00 | 21 / 21 | 78% | 9.14 | 393 / 504 |
| pancreas | 87% | 1024.93 | 286 / 328 | 89% | 7.80 | 158 / 178 |
| uterus | 100% | 2926.31 | 170 / 170 | 73% | 7.70 | 337 / 459 |
| kidney | 99% | 1808.26 | 88 / 89 | 72% | 4.07 | 651 / 901 |
| intestine | 96% | 1806.57 | 931 / 966 | 64% | 3.82 | 336 / 527 |
| stomach | 86% | 1279.17 | 310 / 359 | 70% | 4.61 | 200 / 286 |
| skin | 95% | 1781.95 | 1720 / 1809 | 35% | 1.78 | 163 / 472 |
| spleen | 100% | 2857.70 | 241 / 241 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 100% | 2.24 | 1 / 1 |
| adipose | 100% | 6818.15 | 1203 / 1204 | 0% | 0 | 0 / 0 |
| blood vessel | 98% | 2445.75 | 1309 / 1335 | 0% | 0 | 0 / 0 |
| heart | 90% | 1376.85 | 779 / 861 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 76% | 3.78 | 22 / 29 |
| peripheral blood | 70% | 1223.28 | 652 / 929 | 0% | 0 | 0 / 0 |
| liver | 46% | 413.25 | 105 / 226 | 22% | 1.16 | 90 / 406 |
| tonsil | 0% | 0 | 0 / 0 | 58% | 2.08 | 26 / 45 |
| muscle | 37% | 368.29 | 298 / 803 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 16% | 0.57 | 13 / 80 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0006355 | Biological process | regulation of DNA-templated transcription |
| GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
| GO_0005634 | Cellular component | nucleus |
| GO_0000978 | Molecular function | RNA polymerase II cis-regulatory region sequence-specific DNA binding |
| GO_0003700 | Molecular function | DNA-binding transcription factor activity |
| GO_0000981 | Molecular function | DNA-binding transcription factor activity, RNA polymerase II-specific |
| GO_0008270 | Molecular function | zinc ion binding |
| Gene name | ZNF117 |
| Protein name | Zinc finger protein 117 (Provirus-linked krueppel) (h-PLK) (Zinc finger protein HPF9) |
| Synonyms | |
| Description | FUNCTION: May be involved in transcriptional regulation. |
| Accessions | ENST00000620222.4 Q03924 ENST00000282869.11 |